Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Pella

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 29, 2011
Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programmeDaniel Pella
Archives of Medical Science : AMS|July 31, 2025
Success in achieving LDL-C target values in a high-risk population in Slovakia: the SlovakLipid retrospective studyStefan Toth, Martin Turek, Daniel Pella
Clinical Drug Investigation|April 27, 2016
Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and TolerabilityKatarina Hatalova, Daniel Pella, Rastislav Sidlo, et al.
Central European Journal of Public Health|March 11, 2018
Influence of Demographic Determinants on the Number of Deaths Caused by Circulatory System Diseases in Comparison to the Number of Deaths Caused by Neoplasms in Slovak Regions from 1996-2014Ján Fedačko, Daniel Pella, Beáta Gavurová, et al.
Clinical Drug Investigation|August 11, 2012
Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertensionRobert Hatala, Daniel Pella, Katarína Hatalová, et al.
Archives of Medical Science : AMS|December 17, 2025
Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in SlovakiaMartin Studencan, Daniel Pella, Peter Bramlage, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2005
Can brain dysfunction be a predisposing factor for metabolic syndrome?Ram B Singh, Daniel Pella, Viola Mechirova, et al.
World Journal of Gastroenterology|July 29, 2016
Pleiotropic effects of statins in the diseases of the liverMartin Janicko, Sylvia Drazilova, Daniel Pella, et al.
World Journal of Gastroenterology|January 13, 2016
Association between hepatitis B and metabolic syndrome: Current state of the artPeter Jarcuska, Sylvia Drazilova, Jan Fedacko, et al.
Central European Journal of Public Health|March 11, 2018
Age-adjusted Mortality Rates of Neoplasms and Circulatory System Diseases and Their Demographic Factors in Slovak Regions during 1996-2013Daniel Pella, Ján Fedačko, Rastislav Rajnoha, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 29, 2011
Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programmeDaniel Pella
Archives of Medical Science : AMS|July 31, 2025
Success in achieving LDL-C target values in a high-risk population in Slovakia: the SlovakLipid retrospective studyStefan Toth, Martin Turek, Daniel Pella
Clinical Drug Investigation|April 27, 2016
Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and TolerabilityKatarina Hatalova, Daniel Pella, Rastislav Sidlo, et al.
Central European Journal of Public Health|March 11, 2018
Influence of Demographic Determinants on the Number of Deaths Caused by Circulatory System Diseases in Comparison to the Number of Deaths Caused by Neoplasms in Slovak Regions from 1996-2014Ján Fedačko, Daniel Pella, Beáta Gavurová, et al.
Clinical Drug Investigation|August 11, 2012
Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertensionRobert Hatala, Daniel Pella, Katarína Hatalová, et al.
Archives of Medical Science : AMS|December 17, 2025
Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in SlovakiaMartin Studencan, Daniel Pella, Peter Bramlage, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2005
Can brain dysfunction be a predisposing factor for metabolic syndrome?Ram B Singh, Daniel Pella, Viola Mechirova, et al.
World Journal of Gastroenterology|July 29, 2016
Pleiotropic effects of statins in the diseases of the liverMartin Janicko, Sylvia Drazilova, Daniel Pella, et al.
World Journal of Gastroenterology|January 13, 2016
Association between hepatitis B and metabolic syndrome: Current state of the artPeter Jarcuska, Sylvia Drazilova, Jan Fedacko, et al.
Central European Journal of Public Health|March 11, 2018
Age-adjusted Mortality Rates of Neoplasms and Circulatory System Diseases and Their Demographic Factors in Slovak Regions during 1996-2013Daniel Pella, Ján Fedačko, Rastislav Rajnoha, et al.
Pageof 8